Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001165527-16-000733
Filing Date
2016-04-14
Accepted
2016-04-14 13:04:38
Documents
77
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 g8190a.htm 10-K 2237835
2 ex10-29.htm EX-10.29 187287
3 ex10-30.htm EX-10.30 76959
4 ex10-31.htm EX-10.31 178673
5 ex10-32.htm EX-10.32 84022
6 ex31-1.htm EX-31.1 15650
7 ex32-1.htm EX-32.1 8391
8 g1.jpg GRAPHIC 134247
9 g2.jpg GRAPHIC 134652
10 g3.jpg GRAPHIC 179030
11 g4.jpg GRAPHIC 28498
12 g5.jpg GRAPHIC 217529
13 g6.jpg GRAPHIC 37972
14 g7.jpg GRAPHIC 25817
15 g8.jpg GRAPHIC 65150
16 g9.jpg GRAPHIC 25817
  Complete submission text file 0001165527-16-000733.txt   8477021

Data Files

Seq Description Document Type Size
17 clcs-20151231.xml EX-101.INS 1170089
18 clcs-20151231.xsd EX-101.SCH 51045
19 clcs-20151231_cal.xml EX-101.CAL 37755
20 clcs-20151231_def.xml EX-101.DEF 179550
21 clcs-20151231_lab.xml EX-101.LAB 417678
22 clcs-20151231_pre.xml EX-101.PRE 315632
Mailing Address 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address 65 YIGAL ALON STREET TEL AVIV L3 67433 011 972 3 562-1755
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55413 | Film No.: 161571160
SIC: 2834 Pharmaceutical Preparations